LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 107 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $588 | +27.3% | 242 | 0.0% | 0.00% | – |
| Q4 2022 | $462 | -53.8% | 242 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 242 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 242 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 242 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 242 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 242 | +70.4% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 142 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 142 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |